DOW JONES NEWSWIRES -- Eli Lilly & Co. (LLY) has begun basing employee bonuses partly on advances in its drug research pipeline--a pipeline the struggling company is counting on to brighten its prospects.
DOW JONES NEWSWIRES -- Eli Lilly & Co. (LLY) has begun basing employee bonuses partly on advances in its drug research pipeline--a pipeline the struggling company is counting on to brighten its prospects.
